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Heart disease remains a leading cause of death worldwide. Previ-
ous research has indicated that the dynamics of the cardiac left
ventricle (LV) during diastolic filling may play a critical role in
dictating overall cardiac health. Hence, numerous studies have
aimed to predict and evaluate global cardiac health based on
quantitative parameters describing LV function. However, the
inherent complexity of LV diastole, in its electrical, muscular, and
hemodynamic processes, has prevented the development of tools
to accurately predict and diagnose heart failure at early stages,
when corrective measures are most effective. In this work, it is
demonstrated that major aspects of cardiac function are reflected
uniquely and sensitively in the optimization of vortex formation in
the blood flow during early diastole, as measured by a dimension-
less numerical index. This index of optimal vortex formation
correlates well with existing measures of cardiac health such as the
LV ejection fraction. However, unlike existing measures, this pre-
viously undescribed index does not require patient-specific infor-
mation to determine numerical index values corresponding to
normal function. A study of normal and pathological cardiac health
in human subjects demonstrates the ability of this global index to
distinguish disease states by a straightforward analysis of nonin-
vasive LV measurements.
cardiac dysfunction  left ventricle  mitral flow  biofluid dynamics
Previous research has indicated that dynamics of the cardiacleft ventricle (LV) during diastolic filling play a critical role
in dictating overall cardiac health (1–8). The flow of blood from
the atrium to the ventricle of the left heart during early diastolic
filling, known as the E wave, has been observed in both in vivo
and in vitro studies to cause the formation of a rotating fluid mass
called a vortex ring (9–11, Fig. 1 a and b). This process of vortex
ring formation has been studied extensively in in vitro experi-
ments (12–15), where it has been demonstrated that fluid
transport by vortex ring formation is more efficient than by a
steady, straight jet of f luid (16). Furthermore, it was recently
discovered that energetic constraints limit the maximum growth
of individual vortex rings (14).
These results suggest the possibility that vortex ring formation
may be optimized in naturally occurring fluid transport pro-
cesses, especially in biological systems that depend on efficient
fluid transport for their survival. In ref. 17, in vivo and in vitro
data were used to support the notion that, in principle, the vortex
formation process can dictate optimal kinematics of any biolog-
ical f luid transport system, including the human heart.
In this work, we test the hypothesis that the process of vortex
ring formation during early LV diastole affects cardiac health
and also serves as an indicator of cardiac health. To quantify
the process of vortex ring formation and its potential optimi-
zation, a quantitative index is required. The index is most
useful if it is dimensionless, so that it can be compared across
patient groups. Existing dimensionless measures of cardiac
health, such as the ratio index of diastolic blood f low (i.e., the
relative magnitude of blood f low during the E wave and the
subsequent atrial contraction A wave), cannot be interpreted
without considering patient-specific effects, e.g., the pseudo-
normalization process that occurs in the transition from mild
to moderate dysfunction (18).
Results and Discussion
A dimensionless numerical index has been previously defined to
characterize vortex rings formed by fluid ejected from a rigid
tube (14). This vortex formation time, T  U(t)tD  LD, is
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Fig. 1. Vortex ring formation in vivoand in vitro. (aandb) Map of in vivoblood
flow velocity vectors and vorticity (rotation and shear) contours in the LV of a
human heart during diastole. Images were obtained by magnetic resonance
imaging of a healthy adult (courtesy of the Vascular Imaging Research Center,
Department of Radiology, Veterans Affairs Medical CenterUniversity of Califor-
nia, San Francisco). For emphasis, the LV boundary is indicated by a white line.
Vortical patterns are indicated by the orientation of velocity vectors and by
vorticity contours. Blue and yellow contours indicate clockwise and counterclock-
wise fluid rotation, respectively. (c) Fluorescent dye images of in vitro vortex ring
formation in fluid jets with increasing vortex formation time. (Top) T  2.0.
(Middle) T 3.8. (Bottom) T 14.5. For T 4, vortex ring growth terminates and
fluid is subsequently ejected in a trailing jet. Figure is adapted from ref. 14.
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determined based on the time-averaged speed of the fluid flow
[U(t)], the duration of fluid ejection (t), and the diameter of the
orifice through which the fluid is ejected (D). In effect, the vortex
formation time is a measure of the length-to-diameter ratio
(LD) of the ejected fluid column. A vortex ring will continue
to grow larger during the process of fluid transport until a vortex
formation time T  4 is reached (Fig. 1c). After this point, the
vortex ring is unable to grow larger because of energetic con-
straints (14, 19, 20), and ejected fluid subsequently forms a
trailing jet behind the vortex ring. The transport of fluid by the
trailing jet is less efficient than fluid transport by the vortex ring
(16). Therefore, vortices are optimized for efficient fluid trans-
port when formed during a vortex formation time T 4, i.e., the
largest possible vortex without formation of a trailing jet.
In the left heart, blood flow from the atrium to the ventricle
passes the mitral valve leaflets, which form a time-varying exit
diameter D(t) as opposed to the constant diameter studied in the
experiments noted above and in numerical simulations. The effect
of a time-varying exit diameter on the vortex formation process was
recently studied in vitro (21), where it was shown that for temporal
increases in exit diameter (e.g., the opening of the mitral valve), the
vortex formation time corresponding to maximum vortex growth
remains unchanged atT 4. However, to reach this conclusion, the
definition of the dimensionless numerical index must be revised to
incorporate the time history of the exit diameter: T* U(t)D(t)t,
where the time average is now computed for the ratio of the
instantaneous flow speed and exit diameter (17, 21). With this
amendment, patterns of exit diameter variation as a function of
vortex formation time D(T*) have been devised (17), which use
optimal vortex formation to maximize either the efficiency of fluid
transport or the total momentum (impulse) delivered to the flow by
a biological pump. In ref. 17, the optimization of vortex formation
during squid swimming was deduced, and a similar effect during
cardiac function was hypothesized because similar vortex ring
structures exist in both cases.
As mentioned previously, we hypothesize that disease-related
dysfunctions in steps that precede complete LV diastolic failure
are reflected in the dynamics of transmitral blood flow during
early LV diastole (i.e., during the E wave). If this hypothesis is
valid, then it should be possible to establish a range of values for
the optimal formation time in normal healthy hearts based on
the normal LV ejection fraction (EF), an existing standard
measure for LV function. The desired range can be obtained
from the following equation (see Methods):
T
41 

3EF. [1]
The variable  is a LV geometry parameter defined as

EDV1/3
D
, [2]
where EDV is the LV end-diastolic volume and D is the
time-averaged mitral valve diameter. The parameter  is the
fraction of the stroke volume contributed from LVAwave filling
(i.e., atrial contraction) and is equal to 0.2 in a normal heart at
rest. Therefore, the LV vortex formation time under normal
conditions can be calculated as T  3  EF. From this relation-
ship, one can observe variations of the vortex formation time for
different values of the ejection fraction and ventricular geometry
parameter (). For example, the solid curved line in Fig. 2
indicates that, for EF  0.65 (i.e., the normal range), the vortex
formation time increases with . Calculating  based on normal
human LV values for the end-diastolic volume (EDV) and the
average mitral valve diameter (D ),  ranges between 1.7 and 2.0
(22). Therefore, during normal LV function, the E wave phase
is completed within a vortex formation time 3.3  T  5.5. This
range is consistent with the optimal range of vortex formation
time found in previous in vitro vortex formation studies (14, 21)
and, interestingly, also has been identified as the optimal range
of vortex formation for aquatic locomotion (21, 23). This ob-
served robustness of the optimal vortex formation index suggests
that pathologies in biological f luid transport will be manifested
in changes to this governing parameter.
Indeed, remodeling pathologies of the LV such as mitral valve
stenosis are reflected in an increase of the LV geometry
parameter  (via a decrease in D ), leading to a concomitant
increase in the vortex formation time of up to an order of
magnitude (17). When the LV ejection fraction is reduced, e.g.,
EF3 0.3 in the case of dilated cardiomyopathy (DCM; ref. 22),
the vortex formation time drops significantly from the optimal
value to the range 1.5 to 2.5 (Fig. 2, dashed curved line). Hence,
cardiac pathologies affecting the LV geometry () andor its
function (EF) appear in deviations of the vortex formation time
from its optimal range T*  4.
In further support of these results, two independent studies
were conducted in the Division of Cardiology at the University
of California at San Diego and in the Division of Engineering
and Applied Science at the California Institute of Technology.
A total of 110 volunteers from 5 to 84 years of age were randomly
selected to undergo transthoracic echocardiography for imaging
the left ventricle from the apical view.
Fig. 3 depicts the distribution of total vortex formation time (i.e.,
at the end of the E wave) versus age for the adults (20 years old)
measured in the studies (n 80). Blue circles indicate the calculated
values of vortex formation time for blind test cases where no prior
information about patients’ cardiac health was obtained, and red
squares indicate the data for patients with DCM. The distribution
of vortex formation time corresponding to the blind test converges
to values in the anticipated optimal range between 3.5 and 5.5. The
standard deviation from a least-squares linear fit to the data (SD
1.03; see Fig. 3), and the corresponding histogram (Fig. 3 Inset)
provide quantitative bounds for the range of vortex formation times
for the blind test population. The distribution of vortex formation
times corresponding to the DCM patients is located below the
optimal range, as predicted by the aforementioned relationship
between vortex formation time and ejection fraction (Fig. 2). The
Fig. 2. Quantitative relationship between LV geometry parameter (), LV
ejection fraction, and approximate vortex formation time (T). Horizontal gray
band indicates normal range of LV geometry parameter (). Solid curved line, LV
ejection fraction0.65 (i.e., normal LV function); dashed curved line, LV ejection
fraction0.3 (e.g.,DCM).Thevortexformationtime(T) correspondingtonormal
LV function (i.e., values bounded by vertical dashed lines) is consistent with the
rangeofoptimalvortexformationfoundinprevious invitroexperiments (14,21).
The vortex formation time corresponding to a reduced LV ejection fraction (i.e.,
values bounded by vertical dotted lines) is lower than the optimal range.
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hypothesis of a distinction between the vortex formation time
distributions corresponding to the blind test populationLV function
and the population with DCM is confirmed at a 95% confidence
level by P value calculations from Mann–Whitney and Student’s t
tests of the data sets (P 2.1 105 and 1.2 104, respectively).
A likely source of scatter in the data arises from the use of the
approximated vortex formation time definition of T*, which incor-
porates the maximum mitral valve exit diameter rather than the
time-dependent diameter (see Methods). This approximation was
necessary given the limited temporal and spatial resolution of the
available measurement techniques. Future studies will benefit from
advances in nonintrusive measurement resolution, which should
result in a better understanding of how specific pathophysiological
events are manifested in the relationship between transmitral jet
diameter and the vortex formation time,D(T*), as introduced in ref.
17. It is important to note that the blind test population in Fig. 3may
contain cases of disease progression toward other cardiac pathol-
ogies besides DCM. Although these cases could not be specifically
delineated in this study, they are also expected to deviate from the
optimal range of vortex formation time. The sharply peaked nature
of the histogram in Fig. 3 indicates that the index of optimal vortex
formation introduced here is a sensitive measure of cardiac health.
Methods
Human Subject Measurement Protocol. To evaluate the LV diastolic
filling event and its relationship with cardiac function, the set of
parameters required to determine the dimensionless vortex forma-
tion time T* were recorded. The mitral annulus diameter was used
as the exit diameter (D ), and was measured from long-axis apical
views of the LV at the peak of diastole (i.e., the largest measurable
diameter) and from M mode Doppler images. Mean blood flow
velocity from the atrium to the ventricle of the left heart (i.e.,
transmitral flow U ) was obtained from pulsed-wave Doppler mea-
surements in the immediate downstream vicinity of the opened
mitral valve leaflets. Vortex formation time was then calculated for
each case based on the approximate definition
T
U t
D
, [3]
where t is the duration of the E wave.
Data from human subjects have been obtained through a
protocol and Institutional Review Board approved by the Uni-
versity of California at San Diego medical school and with the
written consent of the volunteers. Ultrasound data from human
subjects were evaluated in double-blind studies by two indepen-
dent observers. A total of six measurements were recorded for
each parameter (i.e.,U ,D , and t). A corresponding random error
of 	 5% is associated with each presented data point.
Derivation of Ejection Fraction and Vortex Formation Time. The term
ejection fraction refers to the ratio of LV stroke volume to the
LV volume at the end of diastole:
EF
EDV ESV
EDV

SV
EDV
, [4]
where EDV is the LV volume at the end of diastole (LV filling),
ESV is the LV volume at the end of systole (LV ejection), and
SV is the stroke volume. The stroke volume can be rewritten as
SV VE VA U EtE

4
D 2 U AtA

4
D 2, [5]
where VE and VA are contributions of the E and A waves during
LV filling and D is the time-averaged mitral valve diameter.
Multiplying both sides of Eq. 5 by 4D 3 and replacing the stroke
volume with Eq. 4:
4
D 3
EFEDV
U EtE
D
  4
D 3
VA , [6]
or
T*
4
D 3

EFEDV VA , [7]
where the approximation sign arises implicitly from the assump-
tion that T*  U tD  T. Denoting , the fraction of the stroke
volume contributed from LV A wave filling (i.e., atrial contrac-
tion) and defining a LV geometry parameter

EDV1/3
D
, [8]
the relationship between LV vortex formation time and the LV
ejection fraction is established:
T
41 

3EF. [9]
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